Analyst Ranking
Bottom 1%
#5165 out of 5212 analysts
Average Return
-8.69%
Win Rate
32%70 out of 216
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Anika Therapeutics IncANIK
+71.05%$8.26$14.12
2025-07-31 -
2026-03-06
Buy
Opko Health IncOPK
+65.31%$0.99$1.63
2024-02-28 -
2025-02-27
Buy
Anika Therapeutics IncANIK
+54.82%$9.12$14.12
2025-09-23 -
2026-03-06
Buy
Lifecore Biomedical IncLFCR
+54.15%$3.25$5.01
2023-03-21 -
2024-03-20
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bioventus IncBVS
2Buy$14.00+66.47%Maintains
3 days ago
Opko Health IncOPK
12Buy$1.50+27.12%Maintains
7 days ago
Dentsply Sirona IncXRAY
23Buy$17.00+33.44%Maintains
7 days ago
Anika Therapeutics IncANIK
17Buy$17.00+20.40%Maintains
10 days ago
Lemaitre Vascular IncLMAT
13Buy$105.00-2.23%Maintains
11 days ago
Orthofix Medical IncOFIX
6Buy$17.00+34.71%Maintains
12 days ago
Merit Medical Systems IncMMSI
26Buy$109.00+50.01%Maintains
12 days ago
Henry Schein IncHSIC
19Buy$97.00+25.00%Maintains
12 days ago
U S Physical Therapy IncUSPH
22Buy$103.00+27.02%Maintains
17 days ago
Haemonetics CorpHAE
25Buy$94.00+46.58%Maintains
a month ago
Option Care Health IncOPCH
19Buy$42.00+40.75%Maintains
2 months ago
Verifyme IncVRME
11Buy$1.50+51.52%Maintains
2 months ago
Modivcare IncMODVQ
13Buy$6.00N/AMaintains
a year ago
Surmodics IncSRDX
5Buy$71.00N/AMaintains
2 years ago
Lifecore Biomedical IncLFCR
9Buy$10.00N/AMaintains
3 years ago
Ati Physical Therapy IncATIP
1Buy$14.00N/AInitiates Coverage On
5 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.